Coda C, Cartia G L, Ciambellotti E
Ospedale degli Infermi, Divisione di Radioterapia e Medicina Nucleare, U.S.S.L. n. 47, Biella.
Minerva Med. 1987 Nov 15;78(21):1611-5.
A nanocolloid marked with 99mTc was used to perform 100 bone marrow scintiscans in 72 patients given radiotherapy for tumours. The compound is taken up by the cells of the phagomonocytic system whose distribution in the bones is similar to that of the erythropoietic marrow. With doses over 30 Gy a more or less marked reduction in captation by the marrow involved in radiation was always noted. The damage remains even for years after radiation, though recovery is possible especially in young patients given moderate doses of up to 40-45 Gy. Bone marrow scintigraphy using a nanocolloid is noninvasive and inexpensive, involves only tiny radiation doses and appears to be useful in the study of cancer patients subjected to radiation treatment either alone or in combination with chemotherapy.
用99mTc标记的纳米胶体对72例接受肿瘤放疗的患者进行了100次骨髓闪烁扫描。该化合物被吞噬单核细胞系统的细胞摄取,其在骨骼中的分布与造血骨髓相似。当剂量超过30 Gy时,总是会注意到受辐射影响的骨髓摄取或多或少明显减少。即使在放疗后数年,损伤仍然存在,不过恢复是可能的,尤其是对于接受中等剂量(高达40 - 45 Gy)的年轻患者。使用纳米胶体进行骨髓闪烁扫描是非侵入性且廉价的,仅涉及微量辐射剂量,并且似乎对单独接受放疗或与化疗联合治疗的癌症患者的研究有用。